Sean A. McCarthy, President and CEO at CytomX Therapeutics, Inc. (CTMX), sold 14,911 shares at $1.42 ($21K) on 2022-07-20, disclosed to the SEC on 2022-07-21.
Open-market sale of $21k CTMX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |
| CTMX | SELL | 2024-08-22 | $17K | — | Filing → |